Chandran, M. http://orcid.org/0000-0001-9119-8443
Mitchell, P. J. http://orcid.org/0000-0002-7439-0369
Amphansap, T. http://orcid.org/0000-0003-2148-3921
Bhadada, S. K.
Chadha, M.
Chan, D.-C.
Chung, Y.-S. http://orcid.org/0000-0003-0179-4386
Ebeling, P.
Gilchrist, N.
Habib Khan, A. http://orcid.org/0000-0001-7693-5740
Halbout, P.
Hew, F. L.
Lan, H.-P. T.
Lau, T. C.
Lee, J. K.
Lekamwasam, S.
Lyubomirsky, G.
Mercado-Asis, L. B.
Mithal, A.
Nguyen, T. V.
Pandey, D.
Reid, I. R.
Suzuki, A.
Chit, T. T.
Tiu, K. L.
Valleenukul, T.
Yung, C. K.
Zhao, Y. L.
,
Article History
Received: 2 October 2020
Accepted: 11 November 2020
First Online: 27 January 2021
Change Date: 27 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00198-021-05953-z
Compliance with ethical standards
:
: A Statement of Disclosure accompanies this submission.Manju Chandran (MC): Chairperson of APCO. MC has received honoraria for lectures organized by DKSH, Amgen, and Zuellig Pharma, and for chairing advisory board meetings for Amgen.Paul Mitchell (PM): PM has undertaken consultancy for governments, national and international osteoporosis societies, healthcare professional organizations and private sector companies relating to systematic approaches to fragility fracture care, and prevention since 2005. PM is a paid consultant for APCO.Tanawat Amphansap (TA): TA has received honoraria for lectures organized by Amgen, DKSH, MSD, and Zuellig Pharma.Manoj Chadha (MC): MC has received honorariums for serving on the steering committee of Amgen’s South East Asia and India Bone Academy Board.Ding-Chen Chan (DC) reports personal fees (consulting fees) from Amgen, Lotus, Eli-Lilly and Harvester Trading Co, Ltd.Peter Ebeling (PE): PE has research funding from Amgen, Eli-Lilly, Novartis, and Alexion and has received honoraria from Amgen and Alexion.Nigel Gilchrist (NG): NG has received research grants from Amgen.Lau TC: has received honoraria for speaking at symposia and financial support for attending symposia by Amgen Pte. Ltd.Lee JK: has received honoraria from Amgen, Mylan, and Zuellig Pharma for speaking at symposia, as member of advisory board and educational programs and workshops.Tuan V. Nguyen (TVN) has received grant support from Amgen and honoraria for lectures and conference engagements from Novartis, MSD, Amgen, and Bridge Health Care.Atsushi Suzuki (AS): AS has received research funding from Chugai Pharmaceutical Co. Ltd., Kowa Co. Ltd., Ono Pharmaceutical Co. Ltd., Taisho Pharmaceutical Co Ltd., and Takeda Pharmaceutical Co. Ltd., and has received symposium honoraria from Asahi Kasei Pharma Co., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eli Lilly Japan K.K., Kyowa Kirin Co. Ltd., and Taisho Pharmaceutical Co. Ltd.Thanut Valleenukul (TV) has received honoraria for lectures organized by AmgenThe following authors declare that they have no conflict of interest: Sanjay Bhadada (SB), Yoon-Sok Chung (YSC), Aysha Habib Khan (AHK), Philippe Halbout (PH), Hew FL, Lan T. H-P, Sarath Lekamwasam (SL), Greg Lyuobomirsky (GL), Leilani B. Mercado-Asis (LBMA), Ambrish Mithal (AM), Dipendra Pandey (DP), Ian R. Reid (IRR), Tet Tun Chit (TTC), Tiu KL, Yung Ck, Zhao YL.
: Not applicable
: Not applicable
: Not applicable
: Not applicable